Triangle Technologies announced today that Mitsui & Co. of Japan signed an exclusive agreement with MedSim Ltd. of Israel to distribute MedSim’s UltraSimâ ultrasound training systems in Japan. The agreement, worth $US 3 million, calls for the distribution of “several dozen” simulators over the course of three years, reported Yoshinori Oikawa of Triangle.

MedSim is a leader in the development, manufacture, marketing and distribution of medical simulation systems. Its simulation systems enable healthcare professionals to expand and enhance their medical knowledge and improve their skills. MedSim also provides training and professional development courses for healthcare practitioners in ultrasound, trauma care, and anesthesiology.

Medsim’s flagship product is the UltraSimâ ultrasound training simulator which allows medical professionals to perform sonography examinations on a mannequin while viewing real-time sonographic images. All the essential data and analysis are also provided y the simulator. There are over one hundred installations of the UltraSimâ worldwide.

“We are extremely proud that a major Japanese institution such as Mitsui has exhibited its belief in Medsim’s technology and markets, and we are confident that this strategic relationship will be one of Medsim’s most successful,” commented Nimrod Gur, Medsim’s founder and CEO.

Medsim has over 55 employees in three offices which are located Israel and the US. In September 1998 MedSim acquired the simulation business of Eagle Simulation, Inc., and its PatSim, patient simulator product line, which has more than 40 worldwide installations.

Mitsui & Co. has revenues of $170 billion and is one of the most influential conglomerates in communications, medical equipment, electronics, and other technology-related areas. Mitsui is one of Japan’s leading trading houses.

“Although not well known to the Israeli public, Mitsui is one of Japan’s most prestigious groups, and occupies a position at the top of the industrial pyramid in Japan,” commented Mr. Oikawa, who manages Triangle’s medical technologies division.

Triangle Technologies is Israel’s leading marketing and investment company active in Japan, and has offices in Ramat-Gan and Tokyo. Triangle’s 12 employees specialize in software, multimedia, Internet, health care and biotechnology, and communications. Triangle has concluded 36 Israel-Japan business agreements, and has raised over $45 million in equity.

For more information, please contact:
Amir Lewkowicz
Triangle Technologies
Tel: +972-3-575-8636
Fax: +972-3-575-8660
a_lewkowicz@triangletech.com